Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial

Lon S. Schneider, Gary W. Small, Susan H. Hamilton, Alexander Bystritsky, Charles Nemeroff, Barnett S. Meyers

Research output: Contribution to journalArticle

265 Citations (Scopus)

Abstract

The estrogen decrease of the postmenopausal state may be a factor in both the pathogenesis of late-life depression and in therapeutic response. Studies of nondepressed women over 60 given estrogen replacement therapy (ERT) suggest improvement in mood. The authors compared clinical response of elderly depressed women outpatients entering a 6-week, randomized, placebo- controlled, double-blind, multicenter trial of fluoxetine (20 mg/day); 72 patients received ERT, and 286 did not. There was a significant interaction between ERT status and treatment effect (P = 0.015). Patients on ERT who received fluoxetine had substantially greater mean Ham-D percentage improvement than patients on ERT who received placebo (40.1% vs. 17.0%, respectively); fluoxetine-treated patients not on ERT did not show benefit significantly greater than placebo-treated patients not on ERT. ERT use may augment fluoxetine response in elderly depressed outpatients and should be considered as a factor in clinical trials in elderly women.

Original languageEnglish
Pages (from-to)97-106
Number of pages10
JournalAmerican Journal of Geriatric Psychiatry
Volume5
Issue number2
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Estrogen Replacement Therapy
Fluoxetine
Geriatrics
Depression
Placebos
Outpatients
Multicenter Studies
Estrogens
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology

Cite this

Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. / Schneider, Lon S.; Small, Gary W.; Hamilton, Susan H.; Bystritsky, Alexander; Nemeroff, Charles; Meyers, Barnett S.

In: American Journal of Geriatric Psychiatry, Vol. 5, No. 2, 01.01.1997, p. 97-106.

Research output: Contribution to journalArticle

Schneider, Lon S. ; Small, Gary W. ; Hamilton, Susan H. ; Bystritsky, Alexander ; Nemeroff, Charles ; Meyers, Barnett S. / Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. In: American Journal of Geriatric Psychiatry. 1997 ; Vol. 5, No. 2. pp. 97-106.
@article{890eeffe93ec496299c169baebfcec66,
title = "Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial",
abstract = "The estrogen decrease of the postmenopausal state may be a factor in both the pathogenesis of late-life depression and in therapeutic response. Studies of nondepressed women over 60 given estrogen replacement therapy (ERT) suggest improvement in mood. The authors compared clinical response of elderly depressed women outpatients entering a 6-week, randomized, placebo- controlled, double-blind, multicenter trial of fluoxetine (20 mg/day); 72 patients received ERT, and 286 did not. There was a significant interaction between ERT status and treatment effect (P = 0.015). Patients on ERT who received fluoxetine had substantially greater mean Ham-D percentage improvement than patients on ERT who received placebo (40.1{\%} vs. 17.0{\%}, respectively); fluoxetine-treated patients not on ERT did not show benefit significantly greater than placebo-treated patients not on ERT. ERT use may augment fluoxetine response in elderly depressed outpatients and should be considered as a factor in clinical trials in elderly women.",
author = "Schneider, {Lon S.} and Small, {Gary W.} and Hamilton, {Susan H.} and Alexander Bystritsky and Charles Nemeroff and Meyers, {Barnett S.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1097/00019442-199700520-00002",
language = "English",
volume = "5",
pages = "97--106",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial

AU - Schneider, Lon S.

AU - Small, Gary W.

AU - Hamilton, Susan H.

AU - Bystritsky, Alexander

AU - Nemeroff, Charles

AU - Meyers, Barnett S.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The estrogen decrease of the postmenopausal state may be a factor in both the pathogenesis of late-life depression and in therapeutic response. Studies of nondepressed women over 60 given estrogen replacement therapy (ERT) suggest improvement in mood. The authors compared clinical response of elderly depressed women outpatients entering a 6-week, randomized, placebo- controlled, double-blind, multicenter trial of fluoxetine (20 mg/day); 72 patients received ERT, and 286 did not. There was a significant interaction between ERT status and treatment effect (P = 0.015). Patients on ERT who received fluoxetine had substantially greater mean Ham-D percentage improvement than patients on ERT who received placebo (40.1% vs. 17.0%, respectively); fluoxetine-treated patients not on ERT did not show benefit significantly greater than placebo-treated patients not on ERT. ERT use may augment fluoxetine response in elderly depressed outpatients and should be considered as a factor in clinical trials in elderly women.

AB - The estrogen decrease of the postmenopausal state may be a factor in both the pathogenesis of late-life depression and in therapeutic response. Studies of nondepressed women over 60 given estrogen replacement therapy (ERT) suggest improvement in mood. The authors compared clinical response of elderly depressed women outpatients entering a 6-week, randomized, placebo- controlled, double-blind, multicenter trial of fluoxetine (20 mg/day); 72 patients received ERT, and 286 did not. There was a significant interaction between ERT status and treatment effect (P = 0.015). Patients on ERT who received fluoxetine had substantially greater mean Ham-D percentage improvement than patients on ERT who received placebo (40.1% vs. 17.0%, respectively); fluoxetine-treated patients not on ERT did not show benefit significantly greater than placebo-treated patients not on ERT. ERT use may augment fluoxetine response in elderly depressed outpatients and should be considered as a factor in clinical trials in elderly women.

UR - http://www.scopus.com/inward/record.url?scp=12644318801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12644318801&partnerID=8YFLogxK

U2 - 10.1097/00019442-199700520-00002

DO - 10.1097/00019442-199700520-00002

M3 - Article

VL - 5

SP - 97

EP - 106

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 2

ER -